CNST News and Press, Constellation Pharmaceuticals Inc. From 05/29/20

CAMBRIDGE, Mass., May 29, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that the Company will participate in an u...

CAMBRIDGE, Mass., May 28, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, will host a virtual analyst/investor event and conferenc...

Continued high rate of SVR35 in 1L patients: 72% at 12 weeks and 67% at 24 weeks SVR35 responses and transfusion dependence conversion observed in 2L monotherapy patients Improvement in bone marrow fibrosis seen across treatment arms Additional data to be presented at EHA fro...

Constellation Pharmaceuticals, Inc. (CNST) Q1 2020 Earnings Conference Call May 6, 2020 8:00 AM ET Company Participants Kia Khaleghpour - Vice President, Investor Relations and Communications Jigar Raythatha - President and Chief Executive Officer Emma Reeve - Chief Financial Off...

Image source: The Motley Fool. Constellation Pharmaceuticals   (NASDAQ: CNST) Q1 2020 Earnings Call May 6, 2020 , 8:00 a.m. ET Operator Continue reading

The following slide deck was published by Constellation Pharmaceuticals, Inc. in conjunction with their 2020 Q1 earnings Read more ...

EHA abstracts to publish on May 14 with an interim update across the MANIFEST trial cohorts Constellation to provide an additional interim update from MANIFEST at EHA in mid-June Company continues to effectively make progress on its milestones in the face of the COVID-19 pandemic ...

CAMBRIDGE, Mass., April 28, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, will host a conference call at 8:00 AM EDT on May 6, 2020, to discuss its ...

Amid widespread uncertainty in healthcare around COVID-19 impact, Baird is focusing on clinical catalysts that continue to power biotech picks - and in particular it's declaring fresh picks on two stocks with data forthcoming. More news on: Constellation Pharmaceuticals, Inc., Blueprint Me...

CAMBRIDGE, Mass., April 06, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that Richard Levy, M.D., has been appoi...